|
|
|
|
|
| |
Wednesday
19
May 2021
|
|
| |
|
|
Time:
|
|
7:30 pm to 9:00 pm
|
| |
|
|
Venue:
|
|
Register online to get the Zoom link |
| |
|
| |
|
|
The Future of Healthcare in the age of AI
According to McKinsey, artificial intelligence (AI) has the potential to transform how care is delivered. It can support improvements in care outcomes, patient experience and access to healthcare services. It can increase productivity and the efficiency of care delivery and allow healthcare systems to provide more and better care to more people. AI can help improve the experience of healthcare practitioners, enabling them to spend more time in direct patient care and reducing burnout. Finally, it can support the faster delivery of care, mainly by accelerating diagnosis time, and help healthcare systems manage population health more proactively, allocating resources to where they can have the largest impact.
Come join this virtual zoom fireside chat featuring a distinguished panel from academia, a government policy maker, an entrepreneur and a VC in the healthcare space.
|
|
|
|
|
|
|
|
|
Jeffrey Nah - Moderator
Jeffrey, a banker turned entrepreneur, investor and lecturer with over 40 years of professional experience spanning 7 countries.
As Venture Builder, Jeff advises startups on business model innovation, go-to-market strategy, leadership & talent development to drive business growth and expansion. He is a Registered Management Consultant (RMC) with the Institute of Management Consultants Singapore.
Startups mentored/invested include those from India, Indonesia, Singapore, Vietnam, Australia, USA. As Venture Builder, he provided market access, talent access and capital access to help the startups scale internationally.
Read More »
|
|
|
|
|
Prof Dean Ho - Panellist
Provost’s Chair Professor Head, Biomechanical Engineering Dept National University of Singapore , PhD, Biomedical Engineering, UCLA
Prof Dean Ho is Provost’s Chair Professor at NUS Biomedical Engineering and NUS Pharmacology, Director of The N.1 Institute for Health (N.1) and Director of The Institute for Digital Medicine (WisDM). He is an elected Fellow of the prestigious US National Academy of Inventors (NAI). This is the highest professional distinction for academic inventors. Prof Ho is recognised for his work in harnessing digital medicine to bring N-of-1 medicine to patients. Prof Ho is currently a Subgroup Lead/Secretariat Member in the World Health Organization AI for Health Working Group for Regulatory Considerations. He has advised major publicly listed companies as well as venture capital and private equity funds in the areas of digital medicine and pharmaceutical development, among other sectors.
Read More »
|
|
|
|
|
Dr Loke Wai Chiong - Panellist
Clinical Director Office for Healthcare Transformation Ministry of Health , UCLA-NUS EMBA 2010
Wai Chiong connects the dots across the health and care continuum; design strategies to move the “big dots” for populations; and continually look for the next disruptive innovation which will transform healthcare. Broad and varied career in government and private sector: as innovator and clinician, operator and investor.
Now back in the public sector, he was previously consultant and advisor to clients across the entire healthcare value chain; serving a portfolio of global investors, governments, NGOs, hospitals and life sciences companies: innovating business models, entering new markets, executing M&A, raising growth capital; effecting business transformation to future-proof organisations; test-bed and deploy new technology or processes while managing day-to-day operations.
Read More »
|
|
|
|
|
Abhinav Girdhar - Panellist
Co-founder & CEO Bodhi Health Education , NUS MBA, 2007
Abhinav is Co-founder of Bodhi Health Education. (www.bodhihealthedu.org) and also an Executive Board Member at VisionSpring India.
He is a 2013 Fellow at Startup Leadership Program (SLP) and has also been an Entrepreneur in Residence at Global Superangels Forum (GSF) Accelerator.
Read More »
|
|
|
|
|
Dr Joseph Mocanu - Panellist
Managing Partner, Verge HealthTech Fund , PhD, Biophysics, University of Toronto
Joseph is a venture capitalist focusing on early stage healthcare technology companies relevant to expanding access, quality and efficiency across emerging markets. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 21 healthcare technology companies to date.
Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.
Read More »
|
|
|
| |
|
